Ziopharm Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Ziopharm Oncology's estimated annual revenue is currently $11.7M per year.
- Ziopharm Oncology's estimated revenue per employee is $191,115
- Ziopharm Oncology's total funding is $277.7M.
- Ziopharm Oncology's current valuation is $204.5M. (January 2022)
Employee Data
- Ziopharm Oncology has 61 Employees.
- Ziopharm Oncology grew their employee count by -54% last year.
Ziopharm Oncology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | EVP, Corporate Development and Investor Relations | Reveal Email/Phone |
3 | Associate Director, Data Management | Reveal Email/Phone |
4 | Associate Director | Reveal Email/Phone |
5 | Senior Director, Investor Relations & Corporate Communications | Reveal Email/Phone |
6 | Materials Manager | Reveal Email/Phone |
7 | Sr. Manager, Cell Therapy Manufacturing Sciences | Reveal Email/Phone |
8 | AD Statistical Programming | Reveal Email/Phone |
9 | Biomarker Discovery Scientist II | Reveal Email/Phone |
10 | Sr. Associate, Genomics | Reveal Email/Phone |
Ziopharm Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 8 | -20% | N/A | N/A |
#4 | $25.7M | 138 | 20% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 41 | -2% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 192 | -7% | N/A | N/A |
What Is Ziopharm Oncology?
ZIOPHARM Oncology, Inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. We are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
keywords:N/A
$277.7M
Total Funding
61
Number of Employees
$11.7M
Revenue (est)
-54%
Employee Growth %
$204.5M
Valuation
N/A
Accelerator
Ziopharm Oncology News
... he served on the Board of Directors at Ziopharm Oncology and held ... Clover Oncology: LiongHo Chua was appointed president of Greater...
Additionally, he served on the Board of Directors at Ziopharm Oncology, and held roles of increasing responsibility at Biogen, Bristol-Myers...
Prior to Ziopharm Oncology, Dr. Baffa was Head of Research & Development and Chief Medical Officer in Medisix Therapeutics,...
Laurence Cooper has done his part. In the five years since he left a tenured position at Houston’s MD Anderson Cancer Center to become CEO of Boston-based Ziopharm, he’s steered the small-cap immunotherapy player through patient deaths in trials, clinical holds, short attacks and, most recently ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.4M | 61 | 3% | $62.6M |
#2 | $11.5M | 61 | -6% | N/A |
#3 | $7.2M | 61 | -9% | $2M |
#4 | $7.7M | 61 | N/A | N/A |
#5 | $13.7M | 61 | N/A | N/A |